Warp Speed’s Woodcock Encourages Institutions To Continue COVID-19 Plasma Controlled Trial

 
• By Brenda Sandburg

Seeking to prevent negative fallout from emergency use authorization, Woodcock and NIH Director Collins ask investigators to prioritize a controlled trial of convalescent plasma currently underway in outpatients.

Coronavirus COVID-19 medical test vaccine research and development concept. Scientist in laboratory study and analyze scientific sample of Coronavirus antibody to produce drug treatment for COVID-19.
Government officials encourage investigators to prioritize a COVID-19 convalescent plasma trial • Source: Shutterstock

More from Clinical Trials

More from R&D